top of page

New Molecular Modalities Mega Webinar

Tuesday, October 31st 2023
Time: 11 a.m. ET / 8 a.m. PT

New Molecular Entity Modalities are changing the drug discovery landscape. It is no longer small molecule and large molecule but more like 13 or more types of molecules that need new processes, informatics, molecular representation, and handling.

Examples of New Molecular Entity Modalities:

  • Antibody Drug Conjugate (ADC)

  • PROTACs

  • Small Molecules

  • Antibodies (Monoclonal , Bispecific, Fragment)

  • Peptide or Protein

  • Nucleotide Based

  • Cell Based

  • In Vivo Expressed Biologics (IVEBs)


We will explore these needs in detail with our sponsors and partners to show you how different companies are making a huge impact in this space!

Thank you to our top sponsor Revvity Signals (formerly P
erkinElmer Informatics)!

AGENDA

ROUND TABLE (1).png

SPONSORS

Adroit DI_Logo.png
Scilligence Logo.jpg

SPEAKERS

Pierre Morieux_Headshot.jpeg

Pierre Morieux, PhD

Chemistry Product Marketing Manager

Revvity Signals

WORLDWIDE

Talk Title:

Visualizing Complex Modalities Made Simple with Signals Notebook

Abstract:

As new modalities like multi-specific antibodies, targeted protein degraders, and oligonucleotide therapeutics reshape the discovery landscape, effectively representing these intricate biological and chemical entities presents new challenges. Without standardized visualizations and notations, inconsistencies can impede collaboration and interpretation. See how Signals Notebook gives you the flexibility to visualize diverse modalities in detail while using HELM to improve clarity and collaboration. Standardize without losing visual impact.

Richard Lingard_Headshot.jpeg

Richard Lingard, PhD

CEO

Adroit DI

WORLDWIDE

Talk Title:

Coming Soon​

Abstract:

Coming Soon

Werngard_Czechtizky_photo.jpg

Werngard Czechtizky, PhD

Executive Director Head Medicinal Chemistry, Respiratory & Immunology

AstraZeneca

WORLDWIDE

Talk Title:

Advances In Inhaled New Modalities - From Preclinical Research Into Clinical Development​

Abstract:

Coming Soon

Tomi Sawyer Headshot.jpeg

Tomi Sawyer, PhD

Chief Drug Hunter & President

Maestro Therapeutics

WORLDWIDE

Talk Title:

Peptide Drug Hunter: Entrepreneurial Science & Innovative Technology Empowering Breakthrough Medicines

Abstract:

Coming Soon

Alan Olague Headshot.jpeg

Alan Olague

Director of Sales & Marketing

Scilligence

WORLDWIDE

Talk Title:

Coming Soon​

Abstract:

Coming Soon

bottom of page